Faculty scientist at nscri.in

Sourav Kumar Nandi

M.Sc in Biotechnology (Senior Research Fellow of ICMR)


1.Nandi SK, Chatterjee N, Roychowdhury T, et al. Kaempferol with Verapamil impeded panoramic chemoevasion pathways in breast cancer through ROS overproduction and disruption of lysosomal biogenesis. Phytomedicine. 2023;113:154689. doi:10.1016/j.phymed.2023.154689

2.Nandi SK, Roychowdhury T, Chattopadhyay S, et al. Deregulation of the CD44-NANOG-MDR1 associated chemoresistance pathways of breast cancer stem cells potentiates the anti-cancer effect of Kaempferol in synergism with Verapamil. Toxicol Appl Pharmacol. 2022;437:115887. doi:10.1016/j.taap.2022.115887

3.Nandi SK, Pradhan A, Das B, et al. Kaempferol attenuates viability of ex-vivo cultured post-NACT breast tumor explants through downregulation of p53 induced stemness, inflammation and apoptosis evasion pathways. Pathol Res Pract. 2022;237:154029. doi:10.1016/j.prp.2022.154029Dr.

4.Guchhait, K. C., Manna, T., Barai, M., Karmakar, M., Nandi, S. K., Jana, D., Dey, A., Panda, S., Raul, P., Patra, A., Bhattacharya, R., Chatterjee, S., Panda, A. K., & Ghosh, C. (2022). Antibiofilm and anticancer activities of unripe and ripe Azadirachta indica (neem) seed extracts. BMC complementary medicine and therapies, 22(1), 42. https://doi.org/10.1186/s12906-022-03513-4

5.Nandi, S.K., Bhattacharya, R., Roychowdhury, T., Roy, U.K., Chattopadhyay, S., & Mukhopadhyay, A. (2019). Ex-vivo drug sensitivity of primary breast cancer stem cell populations to potentiate therapeutic strategy for treatment resistant breast cancer. Annals of Oncology, 29(9), DOI: https://doi.org/10.1093/annonc/mdy428.012

6.Avik Panda, Kuntal Ghosh, Mousumi Ray, Sourav K. Nandi, Saswati Parua (Mondal), Debabrata Bera, Som Nath Singh, Sanjay K. Dwivedi, and Keshab C. Mondal. "Ethnic preparation and quality assessment of Chhurpi, a home-made cheese of Ladakh, India" Journal of ethnic foods 3, no. 4 (2016): 257-262. doi: 10.1016/j.jef.2016.12.004

7.Chakraborty, A. K., K. Poira, D. Saha, C. Halder, S. Das Nandi, S.K. "Multidrug-Resistant bacteria with activated and diversified MDR Genes in Kolkata water: Ganga Action Plan and Heterogeneous Phyto-Antibiotics tackling superbug spread in India." American Journal of Drug Delivery and Therapeutics 5, no. 1 (2018): 1-9.

8.Chakraborty, A.K., Poria, K., Nandi, S.K. (2020). Universal Primer Design for the Detection of Diverged CTX-M Extended-Spectrum β-Lactamases (ESBL) That Give Penicillin and Cephalosporin Resistance During Superbug Infections. In: Sadhukhan, P., Premi, S. (eds) Biotechnological Applications in Human Health. Springer, Singapore. https://doi.org/10.1007/978-981-15-3453-9_6

9.Asit Kumar Chakraborty, Subhankar Bhattacharya, Sourav Kumar Nandi “Cloning, sequencing and BLAST analysis of kDNA minicircles from Leishmania donovani AG83”. Indian Journal of Applied Research. 05(2): 43 – 45, February 2015

Review Article

1.Nandi SK, Basu S, Bhattacharjya A, et al. Interplay of gut microbiome, fatty acids, and the endocannabinoid system in regulating development, progression, immunomodulation, and chemoresistance of cancer. Nutrition. 2022;103-104:111787. doi:10.1016/j.nut.2022.111787

2.Basu, S., Banerjee, N., Nandi, S.K., Das, S., Parmar, K., & Mukhopadhyay, S. (2021). Deregulated molecular genetic pathways in urinary bladder cancer with the importance of molecular biomarkers in diagnosis and follow-up- A comprehensive and updated review. Journal of Clinical and Biomedical Sciences, 11(3), 96-111. DOI: 10.58739/jcbs/v11i3.2.

3.Rittwika Bhattacharyaa,1, Chinmay Kumar Pandab, Sourav K. Nandi a,1, Ashis Mukhopadhyayc,1,⁎ “An insight into metastasis: Random or evolving paradigms?” Pathology - Research and Practice 214 (2018) 1064–107



Escherichia coli strain KT-1_mdr beta-lactamase TEM-1 (blaTEM) gene, blaTEM-1 allele, partialcds GenBank: MF278956.1


  1. ESMO (European Society of Molecular Biology), Asia, November 2018: “Ex-vivo drug sensitivity of primary breast cancer stems cell populations to potentiate therapeutic strategy for treatment resistant breast cancer” Annals of Oncology 29 (suppl_9) DOI: 10.1093/annonc/mdy428.012.  Authors: Sourav Kumar Nandi, R. Bhattacharya, T. Roychowdhury, U.K. Roy , S. Chattopadhyay, A. Mukhopadhyay ; (Impact factor – 18.274)
  2. National Science Congress, Punjab, 2019, for poster presentation: “Role of Kaempferol in attenuation of breast cancer stem cells: an insight into the molecular mechanism” Sourav Kumar Nandi , R. Bhattacharya , T. Roychowdhury , U.K. Roy , S. Chattopadhyay , A. Mukhopadhyay ;
  3. 38th Annual conference of Indian association for cancer research (IACR) for poster presentation under the award category . Presenter: Mr Sourav Nandi, SRF, ICMR. Topic: “Kaempferol, in synergism with Verapamil, attenuates breast cancer stem cell survival through downregulation of iPSC markers and MDR1 expression”
  4. International Conference on Chemistry for Human Development (ICCHD-2020), Organized by Professor Asima Chatterjee Foundation with University of Calcutta and Heritage Institute of Technology (9-11th Jan 2020), on : “ Kaempferol, in synergism with Verapamil, attenuates breast cancer stem cell survival through downregulation cell surface Marker”